Invention Grant
- Patent Title: Use of trans-palmitoleate in identifying and treating metabolic disease
-
Application No.: US15248310Application Date: 2016-08-26
-
Publication No.: US09987243B2Publication Date: 2018-06-05
- Inventor: Dariush Mozaffarian , Haiming Cao , Gokhan S. Hotamisligil
- Applicant: Trustees of Tufts College
- Applicant Address: US MA Medford
- Assignee: Trustees of Tufts College
- Current Assignee: Trustees of Tufts College
- Current Assignee Address: US MA Medford
- Agency: Casimir Jones, S.C.
- Agent Tanya A. Arenson
- Main IPC: A61K31/201
- IPC: A61K31/201 ; A23L33/12 ; A61K31/20 ; C07C57/03 ; A23L33/00 ; A23L33/115
Abstract:
The present invention provides for a novel lipokine, trans-C16:1n7-palmitoleate, which also serves as a biomarker for metabolic status. More specifically, low concentrations of trans-C16:1n7-palmitoleate the serum indicates a risk of metabolic disease. Additionally, administering trans C16:1n7-palmitoleate to a subject (via pharmaceutical, nutraceutical, or other means), positively impacts glucose metabolism.
Public/Granted literature
- US20160361284A1 USE OF TRANS-PALMITOLEATE IN IDENTIFYING AND TREATING METABOLIC DISEASE Public/Granted day:2016-12-15
Information query
IPC分类:
